Abstract:Abstract Background Previous work demonstrated that there are numerous miRNAs in human follicular fluids, some of which are associated with reproductive diseases. In the current study, we sought to determine whether microRNAs (miRNAs) in the follicular fluid (FF) are differentially expressed between women with and without endometriosis and to uncover the association of miRNAs with the oocyte and embryonic development potential. Methods FF was harvested from 30 women with endometriosis and 30 women without who underwent in vitro fertilization treatment at the University Hospital between February and December 2016. The FF samples were subjected to miRNA profiling and validation via quantitative reverse transcription polymerase chain reaction analysis. Mouse/human metaphase-I (MI) oocytes were harvested and micro-injected with an miR-451 inhibitor, and the effects of miR-451 knockdown on Wnt/WNT signalling genes were investigated. Results Oocyte number, fertilization rate, and number of available embryos were decreased significantly in women with endometriosis relative to those without endometriosis. Hsa-miR-451 in FF was downregulated in endometriosis patients relative to control subjects (P < 0.01). Moreover, the proportions of mouse/human MI oocytes that developed into 2-pronuclei (2PN), 2-cell, 8–10-cell and blastocyst-stage embryos were affected by miR-451 knockdown in mouse/human oocytes. Components of the Wnt signalling pathway were aberrantly expressed in the mouse/human oocytes and embryos in the miR-451 inhibitor-injected group. Conclusions miR-451 was downregulated in FF samples from endometriosis patients and was modestly effective in distinguishing endometriosis patients from non-endometriosis patients. miR-451 downregulation in mouse and human oocytes affected pre-implantation embryogenesis by suppressing the Wnt signalling pathway. This miRNA might serve as a novel biomarker of oocyte and embryo quality in assisted reproductive treatment.

microRNAs in female infertility: An overview

MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility

MicroRNAs in Male Fertility

MiRNAs related in signaling pathways of women's reproductive diseases: an overview

MicroRNAs in Ovarian Function and Disorders

MicroRNAs in spermatogenesis dysfunction and male infertility: clinical phenotypes, mechanisms and potential diagnostic biomarkers

Role of miRNAs interference on ovarian functions and premature ovarian failure

MicroRNA-Mediated Gene Regulatory Mechanisms in Mammalian Female Reproductive Health

ΜicroRNA (miRNA) Variants in Male Infertility: Insights from Whole-Genome Sequencing

MicroRNAs, endometrial receptivity and molecular pathways

Genetic associations of miRNA variants (miR-10a, miR-30c, miR-181a, miR-499b) with primary ovarian insufficiency in Korean women

MicroRNA-451 is Downregulated in the Follicular Fluid of Women with Endometriosis and Influences Mouse and Human Embryonic Potential

Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review

The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review

Harnessing the power of miRNAs for precision diagnosis and treatment of male infertility

Cytokine and chemokine profiles in women with endometriosis, polycystic ovary syndrome, and unexplained infertility

Role of Micrornas in Embryo Implantation.

miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery

Mir-192-5p Suppresses Uterine Receptivity Formation Through Impeding Epithelial Transformation During Embryo Implantation.

Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo.

Impact of miRNAs in the pathoetiology of recurrent implantation failure